INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Corporate insider
TC

Thomas John Charles

EVP, General CounselCIK 0002114900

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 2
Max Insider Score20
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
TC
Thomas John CharlesEVP, General Counsel
KRYSKrystal Biotech, Inc.
Option exercise · 10b5-1 plan
M$179K
1,000 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Krystal Biotech, Inc.EVP, General Counsel · May 27, 2026
19
TC
Thomas John CharlesEVP, General Counsel
KRYSKrystal Biotech, Inc.
Open-market sale · 10b5-1 plan
SELL
$347K
1,000 sh
Jun 25, 2026
Jun 26, 2026
traded Jun 25, 2026
+1d
SEC FORM 4

Evidence

0
TC
Thomas John CharlesEVP, General Counsel
KRYSKrystal Biotech, Inc.
Option exercise · 10b5-1 plan
M—
1,000 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC FORM 4

Evidence

20
TC
Thomas John CharlesEVP, General Counsel
KRYSKrystal Biotech, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
642 sh
May 26, 2026May 27, 2026
traded May 26, 2026
+1dSEC FORM 4

Evidence